ALDOA enzyme (up), originally found to be up-regulated in lung cancer (Ojika et al. 1991), was determined to be an indicator of poor prognosis in RCC patients in combination with gamma-enolase (Takashi et al. 1993). Here, ENO2 is linked to renal cell carcinoma.